Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00041951 · ClinicalTrials.gov registry record
Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
A clinical trial of Epilepsy and Seizures, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 185
- Enrollment target
- 1
- Study location
NCT00041951: Completed study of Epilepsy and Seizures, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00041951 is a study of Epilepsy and Seizures that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 185 participants, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00041951, a study of Epilepsy and Seizures, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of our study is to identify gene(s) involved in the cause of childhood absence epilepsy (CAE).
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 1998-12 |
| Est. Completion | 2014-07 |
What the finished NCT00041951 record still lists
NCT00041951 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.
NCT00041951 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00041951 about?
NCT00041951 is a clinical study titled "Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study". The purpose of our study is to identify gene(s) involved in the cause of childhood absence epilepsy (CAE).
What is the current status of trial NCT00041951?
This trial is currently completed. The enrollment target is 185 participants. The study started on 1998-12. Estimated completion is 2014-07.
What conditions does trial NCT00041951 study?
This clinical trial studies the following conditions: Epilepsy, Seizures, Childhood Absence Epilepsy.
Who is sponsoring clinical trial NCT00041951?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00041951 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00041951's enrollment target sits among peer trials
185 36th of 160 higher than 125 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia